Strengthening National Regulatory Authorities in Africa: A Critical Step Towards Enhancing Local Manufacturing of Vaccines and Health Products
Open Access
Abstract
The World Health Organization (WHO) Global Benchmarking Tool (GBT) classifies regulatory systems into four maturity levels, with Maturity Level 3 (ML3) signifying a stable and effective regulatory environment. As of January 2025, eight African nations—Egypt, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania, and Zimbabwe—have attained ML3 status, marking a significant milestone in the continent’s regulatory landscape. Achieving ML3 confers critical benefits, including reducing substandard and falsified medicines, which enhances public health safety and fosters trust in healthcare systems. This progress encourages local manufacturing, diminishing reliance on imported medicines and promoting economic development. Furthermore, ML3 NRAs are better equipped to address public health emergencies, enabling swift approvals for vaccines and therapeutics while upholding safety standards. Nonetheless, challenges persist, including fragmented regulatory systems, the prevalence of counterfeit medicines, and limited resources. Overcoming these hurdles necessitates enhanced organizational capacity, investments in training, and the promotion of collaboration among NRAs. There is an urgent call for greater political commitment and resource allocation to strengthen regulatory systems across Africa. Achieving and maintaining ML3 status is essential for enhancing medicine regulation, supporting local manufacturing, and improving public health outcomes across the continent. While progress has been made, sustained efforts are crucial to tackling existing challenges and harnessing the full potential of advanced regulatory frameworks.Keywords
Funding Information
- Africa Centres for Disease Control and Prevention (Africa CDC)
This publication has 9 references indexed in Scilit:
- Trends in public health emergencies in the WHO African Region: an analysis of the past two decades public health events from 2001 to 2022BMJ Global Health, 2023
- Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase®)Antibiotics, 2023
- Gambian children’s deaths due to contaminated cough syrups are a mutual responsibilityInternational Journal of Surgery, 2023
- Falsified and substandard medicines trafficking: A wakeup call for the African continentPublic Health in Practice, 2022
- Making the investment case for national regulatory authoritiesJournal of Pharmaceutical Policy and Practice, 2021
- The COVID‐19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeuticsClinical and Translational Science, 2020
- Vulnerability of the medical product supply chain: the wake-up call of COVID-19BMJ Quality & Safety, 2020
- Africa Needs a New Public Health Order to Tackle Infectious Disease ThreatsCell, 2020
- Unintended Consequences and Hidden Obstacles in Medicine Access in Sub-Saharan AfricaFrontiers in Public Health, 2019